Prof. Lim is a Senior Consultant Endocrinologist and Head of the Department of Research, Development, and Innovation at Universiti Malaya, Kuala Lumpur, Malaysia. She is the former Head of the Diabetes Care Unit, Universiti Malaya (2022-2025). She also holds honorary positions at the Chinese University of Hong Kong and the Baker Heart and Diabetes Institute, Melbourne, Australia. As a clinician-scientist, Prof. Lim’s major areas of interest are cardiometabolic medicine (epidemiology, molecular, and implementation science).  Prof. Lim sits on the Working Groups of the WHO Global Diabetes Compact, The Lancet Commission on Diabetes, and the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative. She recognizes that every person with diabetes and non-communicable disease (NCD) is unique and warrants personalized care. To revolutionize health care, Prof. Lim aims to advance the implementation of Precision Medicine in Diabetes and NCD, taking into account differences in clinical presentation, genes, and lifestyles in Malaysian populations. These have led to several collaborations with the USA, UK, and other Asian countries. She has published in more than 130 high-impact journals, including The Lancet, Nature, Diabetes Care, and Science Bulletin.  Prof. Lim has received several awards, including the Universiti Malaya’s Top Cited Researcher 2024, World’s Top 2% Scientists by Stanford University for 4 consecutive years (2022-2025), and the European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship, tenable at the University of Oxford, UK. She has also received a scholarship funded by the USA NIH National Institute of General Medical Sciences for training in statistical genetics at the University of Washington, USA.  She is also the Vice President of Diabetes Malaysia (a country affiliate of the International Diabetes Federation) 2025-2027, and the Council Member of the Malaysian Endocrine and Metabolic Society 2022-2026. She is an Editorial Board Member of 4 Q1 Web of Science-indexed journals (BMC Medicine; Diabetes, Obesity and Metabolism; Diabetes/Metabolism Research & Reviews, and Diabetes & Metabolism Journal). Dr. Lim is an article reviewer for 30 leading academic journals, including the European Heart Journal, Diabetes Care, PLoS Medicine, and The Lancet series.

Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

Umi Kalsum Zolkafli @ Zulkifly  holds the Bachelor of Quantity Surveying from Universiti Teknologi Mara. She attained her Master of Science in Construction Contract Management from Universiti Teknologi Malaysia in the year 2008.  She completed her Doctoral degree in Built Environment from Universiti Teknologi Mara in the year 2017 and is now persuading her research interest in construction contract management and professional practice in built environment areas.  She worked with the industry for 10 years prior joining Universiti Malaya, as a Quantity Surveyor and Management Representatives at ARR QS Consultancy. Ever since joining UM as a Lecturer in 10th October 2008, Umi Kalsum Zolkafli @ Zulkifly received the certificate of Excellent Service by UM in the year 2012.  She has produced 2 Master graduates and currently supervising 5 PhDs.  She currently holds 26 publications including books, ISI-ranked articles, Scopus-indexed articles, chapters in book, as well as, in refereed international and national journals. She also has presented papers in conferences locally and internationally.   In addition, she also won Gold, Silver and Bronze awards for her innovation through research and development in multiple national competitions. One of her innovations through community reserach project had also received Intellectual Properties Copyrights. In terms of research grant, Umi Kalsum Zolkafli  has received  in total of RM 2,462,813.66 as principal investigator and co-researcher. She is also a reviewer for multiple international journals and conference proceedings. She is also actively involved with Board of Quantity Surveyors of Malaysia (BQSM) and Royal Institution of Chartered Surveyors Malaysia (RISM) as organizing committee for several international conferences, seminars and workshop Umi Kalsum Zolkafli @ Zulkifly registered as Consultant Quantity Surveyors (CQS) under the Board of Surveyors Malaysia  and a Fellow of The Royal Institution of Surveyors Malaysia (FRISM). She has served as a main committee of Quantity Surveying Division, RISM for more than 5 years.  In addition, she has contributed her expertise in accreditation of Degree programme for public and private Universities under Board of Surveyors Malaysia. She also one of the assessor for the Diploma accreditation programe with Royal Instituitions of Surveyors Malaysia